Alopecia Therapeutics Market: Global Industry Analysis and Forecast (2023-2029)

Alopecia Therapeutics Market size is expected to reach nearly US$ 5.10 Bn. by 2029 with the CAGR of 9.60% during the forecast period.

Alopecia Therapeutics Market Overview:

Alopecia is a condition that leads to severe hair loss or damage, which is caused by certain nutritional problems or medical conditions. It is a type of autoimmune disorder that results in bald spots and partial or complete hair loss. Alopecia Therapeutics Market To know about the Research Methodology :- Request Free Sample Report

Alopecia Therapeutics Market Dynamics:

The rising prevalence of alopecia all over the world is expected to boost demand for alopecia treatment drugs. According to the data published, alopecia affects about 0.7 to 3% of the population in the United States and about 2% of the population in the United Kingdom. Other factors such as the increasing prevalence of chronic diseases around the world, stress disorder, Polycystic Ovary Disease (PCOD), hyperthyroidism, hypothyroidism, cancer, and hypopituitarism also result in Alopecia, which in turn aids the market growth for Alopecia treatment. The increasing demand for hair loss treatment drugs with improved efficacy and reduced side effects is propelling the alopecia treatment market forward. Cytokine therapy and regenerative cell therapy have gained popularity in recent years to treat the different forms of alopecia. In addition to this, combination therapies are also gaining momentum and are expected to create potential growth opportunities in the forecast period. Alopecia can also be treated with a variety of medications and surgical procedures, including hair transplantation, scalp reduction surgery, and others. These procedures contribute to the growth of the Alopecia Therapeutics market. Also, some other key factors such as changing lifestyles increased consumption of alcohol & tobacco, and growing population are also expected to fuel the market growth. Rising awareness for aesthetic appearance, increasing disposable income, ongoing research and development for the production of new therapies impact positively on the market growth. Besides this, certain factors like poor demand for alopecia treatment drugs, high cost of treatment and lack of awareness in underdeveloped countries are anticipated to hamper the growth of Global Alopecia Therapeutics Market. Over the years, the FDA has approved only a few therapies for alopecia treatment, indicating a demand and supply gap that may hamper the global Alopecia Therapeutics market's growth. The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Alopecia Therapeutics Market Segment Analysis:

The Global Alopecia Therapeutics market is segmented on the basis of Disease Type, Gender, Drug Type and Route of Administration. Based on the Disease Type, the Alopecia Areata segment is expected to hold a dominant market share during the forecast period. The segment also held a dominant share of 30% in the year 2022. The segment growth is attributed to certain factors like the high prevalence of the disease worldwide and increasing awareness amongst the people. It is most prevalent in people suffering from autoimmune diseases such as Down’s syndrome, diabetes, and hypothyroidism. Androgenic alopecia is expected to witness the fastest growth, owing to the expected launch of many promising drug candidates as well as an increasing incidence rate. Androgens cause alopecia in people who have a hereditary predisposition to it. Based on the Gender, the male segment is the most dominant segment as the rate of incidence of alopecia is more in men than women. The American Hair Loss Association and the National Library of Medicine states that, almost 50% of men undergo some degree of hair loss by the age of 50. Androgen is a major factor in the development of androgenic alopecia in men. Furthermore, the growing geriatric population and tobacco consumption are two additional factors expected to boost the segment growth. Based on the Drug Type, Minoxidil drug dominates the market and is expected to continue its dominance throughout the forecast period. It is available as the over-the-counter drugs which is the key factor driving its demand. Minoxidil helps in the regrowth of hair or slow the rate of hair loss. The increase in demand for Minoxidil medication for alopecia care is due to certain factors like the rise in prevalence of chronic diseases such as arthritis, depression, hypertension, and cancer treatment that causes hair loss from the patient's body. Alopecia Therapeutics Market segment  

Alopecia Therapeutics Market Regional Insights:

North America is expected to dominate the global Alopecia Therapeutics market during forecast period. North America held a dominant market share of 35% in the year 2022. Because of its technologically advanced healthcare system, high disposable income, and availability of innovative therapeutics options, North America is expected to continue its dominance during the forecast period. Alopecia Areata affects one in every 500 to 1,000 individuals in the United States, states the US National Library of Medicine. APAC is expected to witness lucrative growth opportunities during the forecast years. Due to increased awareness of alopecia treatment and increased acceptance of alopecia treatment products, Asia-Pacific offers potential opportunities for key players in the alopecia treatment industry. Furthermore, improvements in healthcare infrastructure, presence of advanced medical facilities, growth in the R&D sector, an increase in healthcare reforms and technological advances drive the market growth in the region. The report also helps in understanding Global Alopecia Therapeutics Market dynamics, structure by analyzing the market segments and project the Global Alopecia Therapeutics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Alopecia Therapeutics Market make the report investor’s guide.

Alopecia Therapeutics Market Scope: Inquire before buying

Global Alopecia Therapeutics Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018  to 2022 Market Size in 2023: US$ 2.68Bn
Forecast Period 2023 to 2029 CAGR: 9.60% Market Size in 2029: US$ 5.10 Bn
Segments Covered: by Disease Type Androgenic Alopecia Alopecia Areata Ciatricial Alopecia Traction Alopecia Alopecia Totalis
by Gender Male Female
by Drug Type Minoxidil Finasteride Other Drug Types
by Route of Administration Oral Topical Injectable

Alopecia Therapeutics Market, By Region:

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Alopecia Therapeutics Market, Key players:

1. Dr. Reddy’s Laboratories 2. Vitabiotics 3. Merck & Co. 4. Alpecin 5. Cipla 6. Johnson & Johnson 7. Kirkland Signature 8. Phyto Ales Group 9. Lifes2good 10.Teva Pharmaceuticals USA, Inc. 11.Pfizer Inc. 12.GlaxoSmithKline plc 13.Abbott 14.Zydus Pharmaceuticals 15.Sun Pharmaceutical Industries Ltd. 16.Aurobindo Pharma 17.Alès Groupe 18.Gerolymatos International SA 19.Daiichi Sankyo Company Limited 20.Histogen Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Alopecia Therapeutics Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Alopecia Therapeutics Market? Ans: The Global Alopecia Therapeutics Market is growing at a CAGR of 9.60 % during forecasting period 2022-2029. 3. What is scope of the Global Alopecia Therapeutics market report? Ans: Global Alopecia Therapeutics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Alopecia Therapeutics market? Ans: The important key players in the Global Alopecia Therapeutics Market are – Vitabiotics, Merck & Co., Alpecin, Dr. Reddy’s Laboratories, Cipla, Johnson & Johnson, Kirkland Signature, Phyto Ales Group, Lifes2good, Teva Pharmaceuticals USA, Inc., Pfizer Inc., GlaxoSmithKline plc, Abbott, Zydus Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Alès Groupe, Gerolymatos International SA, Daiichi Sankyo Company Limited, and Histogen Inc. 5. What is the study period of this market? Ans: The Global Alopecia Therapeutics Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Alopecia Therapeutics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Alopecia Therapeutics Market 3.4. Geographical Snapshot of the Alopecia Therapeutics Market, By Manufacturer share 4. Global Alopecia Therapeutics Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Alopecia Therapeutics Market 5. Supply Side and Demand Side Indicators 6. Global Alopecia Therapeutics Market Analysis and Forecast, 2022-2029 6.1. Global Alopecia Therapeutics Market Size & Y-o-Y Growth Analysis. 7. Global Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 7.1.1. Androgenic Alopecia 7.1.2. Alopecia Areata 7.1.3. Ciatricial Alopecia 7.1.4. Traction Alopecia 7.1.5. Alopecia Totalis 7.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 7.2.1. Male 7.2.2. Female 7.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 7.3.1. Minoxidil 7.3.2. Finasteride 7.3.3. Other Drug Types 7.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 7.4.1. Oral 7.4.2. Topical 7.4.3. Injectable 8. Global Alopecia Therapeutics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 9.1.1. Androgenic Alopecia 9.1.2. Alopecia Areata 9.1.3. Ciatricial Alopecia 9.1.4. Traction Alopecia 9.1.5. Alopecia Totalis 9.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 9.2.1. Male 9.2.2. Female 9.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 9.3.1. Minoxidil 9.3.2. Finasteride 9.3.3. Other Drug Types 9.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 9.4.1. Oral 9.4.2. Topical 9.4.3. Injectable 10. North America Alopecia Therapeutics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 11.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 12. Canada Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 12.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 13. Mexico Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 13.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 14. Europe Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 14.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 15. Europe Alopecia Therapeutics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 16.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 17. France Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 17.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 18. Germany Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 18.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 19. Italy Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 19.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 20. Spain Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 20.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 21. Sweden Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 21.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 22. CIS Countries Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 22.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 23. Rest of Europe Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 23.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 24. Asia Pacific Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 24.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 25. Asia Pacific Alopecia Therapeutics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 26.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 27. India Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 27.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 28. Japan Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 28.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 29. South Korea Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 29.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 30. Australia Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 30.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 31. ASEAN Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 31.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 32. Rest of Asia Pacific Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 32.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 33. Middle East Africa Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 33.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 34. Middle East Africa Alopecia Therapeutics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 35.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 36. GCC Countries Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 36.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 37. Egypt Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 37.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 38. Nigeria Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 38.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 39. Rest of ME&A Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 39.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 40. South America Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 40.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 41. South America Alopecia Therapeutics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 42.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 43. Argentina Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 43.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 44. Rest of South America Alopecia Therapeutics Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Gender, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 44.4. Market Size (Value) Estimates & Forecast By Route of Administration, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Alopecia Therapeutics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Vitabiotics 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Merck & Co. 45.3.3. Alpecin 45.3.4. Dr. Reddy’s Laboratories 45.3.5. Cipla 45.3.6. Johnson & Johnson 45.3.7. Kirkland Signature 45.3.8. Phyto Ales Group 45.3.9. Lifes2good 45.3.10. Teva Pharmaceuticals USA, Inc. 45.3.11. Pfizer Inc. 45.3.12. GlaxoSmithKline plc 45.3.13. Abbott 45.3.14. Zydus Pharmaceuticals 45.3.15. Sun Pharmaceutical Industries Ltd. 45.3.16. Aurobindo Pharma 45.3.17. Alès Groupe 45.3.18. Gerolymatos International SA 45.3.19. Daiichi Sankyo Company Limited 45.3.20. Histogen Inc. 46. Primary Key Insights
  • INQUIRE BEFORE BUYING